Watson recalls one Propafenone HCL lot

Watson Pharmaceuticals is voluntarily recalling one lot of Propafenone HCL after it discovered that the drug, which is used to irregular heartbeats, may contain more of the active ingredient than it should. The lot in question was shipped to customers between October 15 and November 26, 2008. Report

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.